Skip to main content
Top
Published in: BMC Public Health 1/2016

Open Access 01-12-2016 | Research article

Findings from a comprehensive diarrhoea prevention and treatment programme in Lusaka, Zambia

Authors: Samuel Bosomprah, Lauren B. Beach, Laura K. Beres, Jonathan Newman, Kabwe Kapasa, Cheryl Rudd, Lungowe Njobvu, Brad Guffey, Sydney Hubbard, Karen Foo, Carolyn Bolton-Moore, Jeffrey Stringer, Roma Chilengi

Published in: BMC Public Health | Issue 1/2016

Login to get access

Abstract

Background

The Programme for the Awareness and Elimination of Diarrhoea (PAED) was a pilot comprehensive diarrhoea prevention and control programme aimed to reduce post-neonatal, all-cause under-five mortality by 15 % in Lusaka Province. Interventions included introduction of the rotavirus vaccine, improved clinical case management of diarrhoea, and a comprehensive community prevention and advocacy campaign on hand washing with soap, exclusive breastfeeding up to 6 months of age, and the use of ORS and Zinc. This study aimed to assess the impact of PAED on under-5 mortality.

Methods

The study was a pre-post evaluation design. The Demographic and Health Survey style population-based two-stage approach was used to collect data at the beginning of the intervention and 3 years following the start of intervention implementation in Lusaka province. The primary outcome of interest was an all-cause, post-neonatal under-five mortality rate defined as the probability of dying after the 28th day and before the fifth birthday among children aged 1–59 months. The Kaplan-Meier time to event analysis was used to estimate the probability of death; multiplying this probability by 1000 to yield the post-neonatal mortality rate. Survival-time inverse probability weighting model was used to estimate Average Treatment Effect (ATE).

Results

The percentage of children under age 5 who had diarrhoea in the last 2 weeks preceding the survey declined from 15.8 % (95 % CI: 15.2 %, 16.4 %) in 2012 to 12.7 % (95 % CI: 12.3 %, 13.2 %) in 2015. Over the same period, mortality in post-neonatal children under 5 years of age declined by 34 %, from an estimated rate of 29 deaths per 1000 live births (95 % CI: (26, 32) death per 1000 live births) to 19 deaths per 1000 live births (95 % CI: (16, 21) death per 1000 live births). When every child in the population of children aged 1–59 months is exposed to the intervention, the average time-to-death was estimated to be about 8 months more than when no child is exposed (ATE = 7.9; 95 % CI: 4.4,11.5; P < 0.001).

Conclusion

Well-packaged diarrhoea preventive and treatment interventions delivered at the clinic and community-level could potentially reduce probability of death among children aged 1–59 months.
Literature
1.
go back to reference The UN Inter-agency Group for Child Mortality Estimation. Levels and trends in child mortality: report 2015. New York: UNICEF; 2015. The UN Inter-agency Group for Child Mortality Estimation. Levels and trends in child mortality: report 2015. New York: UNICEF; 2015.
2.
go back to reference Liu L, Oza S, Hogan D, Perin J, Rudan I, Lawn J, Cousens S, Mathers C, Black R. Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet. 2015;385:430–40.CrossRefPubMed Liu L, Oza S, Hogan D, Perin J, Rudan I, Lawn J, Cousens S, Mathers C, Black R. Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet. 2015;385:430–40.CrossRefPubMed
3.
go back to reference World Health Organisation. Generic protocol for monitoring impact of rotavirus vaccination on gastroenteritis disease burden and viral strains. Geneva: WHO Press; 2008. World Health Organisation. Generic protocol for monitoring impact of rotavirus vaccination on gastroenteritis disease burden and viral strains. Geneva: WHO Press; 2008.
4.
go back to reference Central Statistical Office (CSO) [Zambia], Ministry of Health (MOH) [Zambia], ICF, International. Zambia Demographic and Health Survey 2013–14. Rockville: Central Statistical Office, Ministry of Health, and ICF International; 2014. Central Statistical Office (CSO) [Zambia], Ministry of Health (MOH) [Zambia], ICF, International. Zambia Demographic and Health Survey 2013–14. Rockville: Central Statistical Office, Ministry of Health, and ICF International; 2014.
5.
go back to reference Madhi S, Cunliffe N, Steele D, Witte D, Kirsten M, Louw C, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med. 2010;362(4):289–98.CrossRefPubMed Madhi S, Cunliffe N, Steele D, Witte D, Kirsten M, Louw C, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med. 2010;362(4):289–98.CrossRefPubMed
6.
go back to reference Linhares A, Velazquez F, Perez-Schael I, Saez-Llorens X, Abate H, Espinoza F, et al. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. Lancet. 2008;371(9619):1181–9.CrossRefPubMed Linhares A, Velazquez F, Perez-Schael I, Saez-Llorens X, Abate H, Espinoza F, et al. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. Lancet. 2008;371(9619):1181–9.CrossRefPubMed
7.
go back to reference Vesikari T, Karvonen A, Prymula R, Schuster V, Tejedor J, Cohen R, et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet. 2007;370(9601):1757–63.CrossRefPubMed Vesikari T, Karvonen A, Prymula R, Schuster V, Tejedor J, Cohen R, et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet. 2007;370(9601):1757–63.CrossRefPubMed
8.
go back to reference De Vos B, Han H, Bouckenooghe A, Debrus S, Gillard P, Ward R, et al. Live attenuated human rotavirus vaccine, RIX4414, provides clinical protection in infants against rotavirus strains with and without shared G and P genotypes: integrated analysis of randomized controlled trials. Pediatr Infect Dis J. 2009;28(4):261–6.CrossRefPubMed De Vos B, Han H, Bouckenooghe A, Debrus S, Gillard P, Ward R, et al. Live attenuated human rotavirus vaccine, RIX4414, provides clinical protection in infants against rotavirus strains with and without shared G and P genotypes: integrated analysis of randomized controlled trials. Pediatr Infect Dis J. 2009;28(4):261–6.CrossRefPubMed
9.
go back to reference Chilengi R, Rudd C, Bolton C, Guffey B, Masumbu P, Stringer J. Successes, Challenges and Lessons Learned in Accelerating Introduction of Rotavirus immunisation in Zambia. World J Vaccin. 2015;5:43–53.CrossRef Chilengi R, Rudd C, Bolton C, Guffey B, Masumbu P, Stringer J. Successes, Challenges and Lessons Learned in Accelerating Introduction of Rotavirus immunisation in Zambia. World J Vaccin. 2015;5:43–53.CrossRef
12.
go back to reference World Health Organization. EVERY NEWBORN An Action Plan To End Preventable Deaths. 2014. World Health Organization. EVERY NEWBORN An Action Plan To End Preventable Deaths. 2014.
13.
go back to reference Central Statistical Office (CSO) [Zambia]. Zambia 2010 census of population and housing: National analytical report, vol. 11. 2010. Central Statistical Office (CSO) [Zambia]. Zambia 2010 census of population and housing: National analytical report, vol. 11. 2010.
14.
go back to reference Cairncross S, Hunt C, Boisson S, Bostoen K, Curtis V, Fung IC, Schmidt W-P. Water, sanitation and hygiene for the prevention of diarrhoea. Int J Epidemiol. 2010;39:i193–205.CrossRefPubMedPubMedCentral Cairncross S, Hunt C, Boisson S, Bostoen K, Curtis V, Fung IC, Schmidt W-P. Water, sanitation and hygiene for the prevention of diarrhoea. Int J Epidemiol. 2010;39:i193–205.CrossRefPubMedPubMedCentral
15.
go back to reference Ejemot-Nwadiaro R, Ehiri J, Arikpo D, Meremikwu M, Critchley J. Hand washing promotion for preventing diarrhoea. Cochrane Database of Systematic Reviews. 2015;(Issue 9):Art. No.: CD004265. DOI:004210.001002/14651858.CD14004265.pub14651853. Ejemot-Nwadiaro R, Ehiri J, Arikpo D, Meremikwu M, Critchley J. Hand washing promotion for preventing diarrhoea. Cochrane Database of Systematic Reviews. 2015;(Issue 9):Art. No.: CD004265. DOI:004210.001002/14651858.CD14004265.pub14651853.
16.
go back to reference Walker C, Black R. Rotavirus vaccine and diarrhea mortality: quantifying regional variation in effect size. BMC Public Health. 2011;11 Suppl 3:S16.CrossRef Walker C, Black R. Rotavirus vaccine and diarrhea mortality: quantifying regional variation in effect size. BMC Public Health. 2011;11 Suppl 3:S16.CrossRef
17.
go back to reference Munos M, Walker C, Black R. The effect of oral rehydration solution and recommended home fluids on diarrhoea mortality. Int J Epidemiol. 2010;39:i75–87.CrossRefPubMedPubMedCentral Munos M, Walker C, Black R. The effect of oral rehydration solution and recommended home fluids on diarrhoea mortality. Int J Epidemiol. 2010;39:i75–87.CrossRefPubMedPubMedCentral
18.
go back to reference Chilengi R, Mudenda M, Siwale Z, Simuyandi M: ORS and Zinc supply chain in zambia- a structural bottleneck to diarrhoea case management. BMC Health Serv Res, Under review. Chilengi R, Mudenda M, Siwale Z, Simuyandi M: ORS and Zinc supply chain in zambia- a structural bottleneck to diarrhoea case management. BMC Health Serv Res, Under review.
20.
go back to reference Manesh AO, Sheldon TA, Pickett KE, Carr-Hill R. Accuracy of child morbidity data in demographic and health surveys. Int J Epidemiol. 2008;37(1):194–200.CrossRefPubMed Manesh AO, Sheldon TA, Pickett KE, Carr-Hill R. Accuracy of child morbidity data in demographic and health surveys. Int J Epidemiol. 2008;37(1):194–200.CrossRefPubMed
21.
go back to reference Snow RW, Basto de Azevedo I, Forster D, Mwankuyse S, Bomu G, Kassiga G, Nyamawi C, Teuscher T, Marsh K. Maternal recall of symptoms associated with childhood deaths in rural east Africa. Int J Epidemiol. 1993;22(4):677–83.CrossRefPubMed Snow RW, Basto de Azevedo I, Forster D, Mwankuyse S, Bomu G, Kassiga G, Nyamawi C, Teuscher T, Marsh K. Maternal recall of symptoms associated with childhood deaths in rural east Africa. Int J Epidemiol. 1993;22(4):677–83.CrossRefPubMed
22.
go back to reference Boerma JT, Sommerfelt AE. Demographic and health surveys (DHS): contributions and limitations. World Health Stat Q. 1993;46(4):222–6.PubMed Boerma JT, Sommerfelt AE. Demographic and health surveys (DHS): contributions and limitations. World Health Stat Q. 1993;46(4):222–6.PubMed
Metadata
Title
Findings from a comprehensive diarrhoea prevention and treatment programme in Lusaka, Zambia
Authors
Samuel Bosomprah
Lauren B. Beach
Laura K. Beres
Jonathan Newman
Kabwe Kapasa
Cheryl Rudd
Lungowe Njobvu
Brad Guffey
Sydney Hubbard
Karen Foo
Carolyn Bolton-Moore
Jeffrey Stringer
Roma Chilengi
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2016
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-016-3089-7

Other articles of this Issue 1/2016

BMC Public Health 1/2016 Go to the issue